Expanded Access to Hemlibra for Moderate Hemophilia A
Canadian Blood Services (CBS) announced in May that the provinces and territories have agreed to expand access to emicizumab (Hemlibra) for people with moderate hemophilia A and a severe […]
Hemlibra
Hemlibra Access
After a long campaign and many challenges, the Quebec chapter of the Canadian Hemophilia Society and the Canadian Hemophilia society have succeeded in making Hemlibra available to all non-inhibitor […]
Hemlibra Approved in Canada!
Please see the announcement from the Canadian Hemophilia Society detailing the successful conclusion of our advocacy campaign to make Hemlibra available to all severe non-inhibitor hemophilia A patients. Hemophilia Ontario […]
